Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.

In a study of 24-month-old rats, equivalent to human centenarians, the team blocked one of the digestive enzymes, pancreatic trypsin, using a two-week oral treatment with a serine protease ...